Market Overview

Benzinga's Top Downgrades

Related BDX
Medical Device ETF in Focus on Recent Merger Activity - ETF News And Commentary
Stifel: CareFusion Corporation Deal May Have Far-Flung Effects
Related URBN
Markets Boosted From Strong Earnings Releases, Jobless Benefits
Consumer Discretionary ETF Gaining Momentum
Earnings Not Inspiring Holiday Shopping Spirits (Fox Business)

Analysts at Mizuho downgraded Becton, Dickinson and Company (NYSE: BDX) from “buy” to “neutral.” The target price for Becton Dickinson is set to $87. Becton Dickinson's shares closed at $83.94 on Friday.

Analysts at Atlantic Equities downgraded Urban Outfitters (NASDAQ: URBN) from “overweight” to “neutral.” The target price for Urban Outfitters is set to $44. Urban Outfitters' shares closed at $43.39 on Friday.

Analysts at Susquehanna downgraded Morgan Stanley (NYSE: MS) from “positive” to “neutral.” The target price for Morgan Stanley is set to $24. Morgan Stanley's shares closed at $22.38 on Friday.

Credit Suisse downgraded Amgen (NASDAQ: AMGN) from “outperform” to “neutral.” The target price for Amgen has been lowered from $100 to $90. Amgen's shares closed at $82.08 on Friday.

Latest Ratings for BDX

DateFirmActionFromTo
Oct 2014Bank of AmericaMaintainsNeutral
Oct 2014Canaccord GenuityMaintainsHold
Oct 2014Argus ResearchMaintainsBuy

View More Analyst Ratings for BDX
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (AMGN + BDX)

Around the Web, We're Loving...

Get Benzinga's Newsletters